About Incontinence - Treatment Options - Hormone Replacement Therapy
Medical Reviewer: Catherine DuBeau, M.D.
Hormone Replacement Therapy (HRT), also called Estrogen Replacement Therapy (ERT), is most commonly given to women during or after menopause to help alleviate the symptoms of menopause.
HRT and ERT are not effective to treat incontinence, and several studies demonstrate that estrogen causes or worsens urinary incontinence in postmenopausal women.
Dr. Catherine E. DuBeau is an Associate Professor of Medicine in the Section of Geriatrics at the University of Chicago . She has been actively engaged in teaching, management, and research regarding urinary incontinence in older persons for nearly 15 years. Her research focuses on quality of life impact and patient-centered outcomes. She has published numerous articles and book chapters on urinary incontinence and benign prostate disease in such publications as the Journal of the American Geriatrics Society, Journal of Urology, American Geriatric Society (AGS) Geriatric Review Syllabus, Cassell et al's Geriatric Medicine, Oxford Textbook of Geriatric Medicine, the on-line textbook UpToDate, and Chapple et al’s upcoming Multidisciplinary Management of Female Pelvic Floor Dysfunction. She was a member of the Urinary Incontinence Technical Subgroup of the National Committee for Quality Assurance that developed the Health Plan Employer Data and Information Set (HEDISâ) regarding urinary incontinence, and chaired the Evaluation Committee for developing the National Association for Continence (NAFC) Blueprint for Continence Care in Assisted Living. Dr. DuBeau most recently co-chaired the Frail Elderly Committee for the 2004 3rd International Consultation on Incontinence. She is a member of the Editorial Board of the Journal of the American Geriatrics Society, and in 2004 was awarded the AGS/NAFC Continence Care Champion Award. She is a dedicated teacher and lectures nationally and internationally on incontinence.
Page last modified 25 July 2009